Ondine Biomedical Inc. (OBI.L) LSE

18.00

+1.75(+10.77%)

Updated at August 18 05:42PM

Currency In GBp

Valuation

Market Cap43.23M
Enterprise Value43.23M
P/E Ratio-4.83
PEG Ratio-0.05
Price/Sales Ratio72.76
Price/Book Ratio44.2
Enterprise/Revenue71.57
Enterprise/EBITDA-7.93

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2023

Profitability

Profit Margin-9.32
Operating Margin-9.49

Management Effectiveness

Return On Assets-3.33
Return On Equity-2.78

Income Statement

Revenue2.05M
Revenue/Share0.01
Gross Profit1.32M
EBITDA-18.49M
Net Income-19.1M
Diluted EPS-0.07

Balance Sheet

Total Cash2.98M
Total Cash/Share0.01
Total Debt541,000
Total Debt/Equity0.26
Current Ratio1.36
Book Value Per Share0.01

Price History

52-Week Change148.28
52-Week High18.5
52-Week Low5.5
Moving Average 50 Days13.32
Moving Average 200 Days10.5

Statistics

Average Volume228,235
Shares Outstanding444.23M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A